Acadia Pharmaceuticals Inc.
Clinical trials sponsored by Acadia Pharmaceuticals Inc., explained in plain language.
-
New hope for depression that Won't respond to current medications
Disease control Recruiting nowThis study is testing whether an experimental medication called ACP-211 can help adults with major depressive disorder who haven't gotten better with standard antidepressant treatments. Researchers will compare ACP-211 against a placebo (inactive pill) to see if it reduces depres…
Phase: PHASE2 • Sponsor: ACADIA Pharmaceuticals Inc. • Aim: Disease control
Last updated Apr 22, 2026 15:58 UTC
-
New hope for dementia psychosis: experimental drug enters key trial
Symptom relief Recruiting nowThis study tests an experimental drug called ACP-204 to see if it can reduce hallucinations and delusions in people with Lewy body dementia. About 180 adults aged 55 to 84 will receive either the drug or a placebo for 6 weeks. The goal is to measure changes in psychosis symptoms …
Phase: PHASE2 • Sponsor: ACADIA Pharmaceuticals Inc. • Aim: Symptom relief
Last updated May 11, 2026 20:54 UTC
-
New hope for Alzheimer's psychosis: drug trial targets hallucinations
Symptom relief Recruiting nowThis study tests an experimental drug called ACP-204 to see if it can reduce hallucinations and delusions in people with Alzheimer's disease psychosis. About 1,074 adults aged 55 to 95 will receive either the drug or a placebo for 6 weeks. The goal is to improve symptoms without …
Phase: PHASE2, PHASE3 • Sponsor: ACADIA Pharmaceuticals Inc. • Aim: Symptom relief
Last updated May 05, 2026 11:52 UTC